Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Cancer

Explore clinical trials studying Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

242 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Cancer trial results

Completed

Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy

NCT00415363

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Copenhagen, Denmark
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergen, Norway
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trondheim, Norway
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Olsztyn, Poland
View Trial Details
Completed

Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)

NCT02499770

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • Memorial Hospital - Univ. of Colorado Health Colorado Springs, Colorado, United States
View all 40 locations
View Trial Details
Completed

Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer

NCT02289690

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Mayo Clinic - Scottsdale /ID# 129127 Scottsdale, Arizona, United States
  • Univ of Colorado Cancer Center /ID# 129220 Aurora, Colorado, United States
  • Emory University Hospital /ID# 141682 Atlanta, Georgia, United States
  • Georgia Regents University /ID# 148567 Augusta, Georgia, United States
View all 62 locations
View Trial Details
Completed

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

NCT02223052

Conditions
Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +106 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer

NCT02735980

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
View all 41 locations
View Trial Details

Related conditions